R Lenkei
Overview
Explore the profile of R Lenkei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lenkei R, Gratama J, Rothe G, Schmitz G, DHautcourt J, Arekrans A, et al.
Cytometry
. 1998 Oct;
33(2):188-96.
PMID: 9773879
In the frame of the activities initiated by the Task Force for Antigen Quantitation of the European Working Group on Clinical Cell Analysis (EWGCCA), an experiment was conducted to evaluate...
12.
Gratama J, DHautcourt J, Mandy F, Rothe G, Barnett D, Janossy G, et al.
Cytometry
. 1998 Oct;
33(2):166-78.
PMID: 9773877
Quantitation of immunofluorescence intensity serves to estimate the number of defined molecules expressed on or in cells. Clinical applications of this diagnostic tool are increasing, e.g., aberrant expression of various...
13.
Lenkei R, Bratt G, Holmberg V, Muirhead K, Sandstrom E
Cytometry
. 1998 Oct;
33(2):115-22.
PMID: 9773871
Increased activation of CD8+ T cells, particularly increased expression of CD38 antigen, has been shown to strongly correlate with progression of human immunodeficiency virus-positive (HIV+) individuals to acquired immunodeficiency syndrome...
14.
Matsuda M, Ulfgren A, Lenkei R, Petersson M, Ochoa A, Lindblad S, et al.
Scand J Immunol
. 1998 Mar;
47(3):254-62.
PMID: 9519864
Although T cells from patients with rheumatoid arthritis (RA) have previously been determined to have poor proliferative responses to a variety of stimuli, the underlying mechanism is not known. We...
15.
Lenkei R, Andersson B
Clin Immunol Immunopathol
. 1995 Nov;
77(2):131-8.
PMID: 7586720
Blood samples of 58 blood donors (ages 19-64 years, 31 males and 27 females) were investigated with three-color, quantitative flow cytometry. IgG anti-cytomegalovirus (CMV) was estimated with ELISA. Nineteen men...
16.
Lenkei R, Andersson B
J Immunol Methods
. 1995 Jun;
183(2):267-77.
PMID: 7602149
The relative density of lymphocyte CD3, CD4, CD5, CD8, CD20, CD23, CD28, CD38, CD45RA, CD45RO, CD57 and HLA-DR antigens was measured as antibody binding capacity (ABC) in 58 blood donors...
17.
Matsuda M, Petersson M, Lenkei R, Taupin J, Magnusson I, Mellstedt H, et al.
Int J Cancer
. 1995 Jun;
61(6):765-72.
PMID: 7790109
T cells from mice bearing an experimental colon carcinoma, and from patients with colorectal and renal carcinomas, have atypical T-cell receptors (TCR). In the present study, further characterization of modulations...
18.
Juliusson G, Lenkei R, Tjonnfjord G, Heldal D, Liliemark J
Ann Oncol
. 1995 Apr;
6(4):371-5.
PMID: 7619752
Background: Neutropenic fever is the commonest complication of cladribine therapy for hairy-cell leukemia (HCL), leading to a 3% mortality rate. Our aim was to identify predictive factors and evaluate the...
19.
Juliusson G, Lenkei R, Tjonnfjord G, Heldal D, Liliemark J
Br J Haematol
. 1995 Mar;
89(3):637-9.
PMID: 7734367
Cladribine is an effective therapy for hairy cell leukaemia (HCL), but the standard regime is frequently complicated by neutropenic fever and prolonged T-cell depression. We studied 102 patients with active...
20.
Juliusson G, Lenkei R, Liliemark J
Blood
. 1994 Jun;
83(12):3672-81.
PMID: 7911341
By flow cytometry and an extensive set of markers, we characterized leukemic cells from the blood and bone marrow of 68 symptomatic patients with hairy cell leukemia (HCL). Hairy cells...